Decentrialz logo
  • HIPAA Compliant
  • ISO 27001 Certified
Find Trials
About UsContact
Become a Volunteer+1 877 705 1914

Status:

COMPLETED

Norms Expansion and Validation for IntelliSpace Cognition

Lead Sponsor:

Philips Electronics Nederland B.V. acting through Philips CTO organization

Collaborating Sponsors:

Research America Inc.

Qserve

Conditions:

Cognitive Functioning of Healthy Individuals

Eligibility:

All Genders

18-95 years

Phase:

NA

Brief Summary

This study aims to expand the normative dataset for Philips IntelliSpace Cognition to include ages 18-49 and 80+ and aims to validate two new digital tests.

Eligibility Criteria

Inclusion

  • Participant is 18 years or older.
  • Participant's primary language (language most often spoken) must be American English.
  • Participant is able to see well (naturally or corrected by means of eyeglasses or lenses).
  • Participant is able to hear well (naturally of corrected by means of a hearing aid).
  • Participant is able to use their fingers, hands and arms to write symbols.
  • Participant has valid health insurance in USA.
  • Participant is able to give informed consent.
  • Participant is able to understand test instructions and participate fully in testing.
  • Participant has normal fine and gross motor ability.

Exclusion

  • Inclusion Criteria:
  • Participant is 18 years or older.
  • Participant's primary language (language most often spoken) must be American English.
  • Participant is able to see well (naturally or corrected by means of eyeglasses or lenses).
  • Participant is able to hear well (naturally of corrected by means of a hearing aid).
  • Participant is able to use their fingers, hands and arms to write symbols.
  • Participant has valid health insurance in USA.
  • Participant is able to give informed consent.
  • Participant is able to understand test instructions and participate fully in testing.
  • Participant has normal fine and gross motor ability.

Key Trial Info

Start Date :

March 8 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 2 2021

Estimated Enrollment :

508 Patients enrolled

Trial Details

Trial ID

NCT04729257

Start Date

March 8 2021

End Date

July 2 2021

Last Update

October 12 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Research America Inc.

Newtown Square, Pennsylvania, United States, 19073